Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

Autor:	Szabados, Bernadett1,2 (AUTHOR), Kockx, Mark3 (AUTHOR), Assaf, Zoe June4 (AUTHOR), van Dam, Pieter-Jan3 (AUTHOR), Rodriguez-Vida, Alejo5 (AUTHOR), Duran, Ignacio6 (AUTHOR), Crabb, Simon J.7 (AUTHOR), Van Der Heijden, Michiel S.8 (AUTHOR), Pous, Albert Font9 (AUTHOR), Gravis, Gwenaelle10 (AUTHOR), Herranz, Urbano Anido11 (AUTHOR), Protheroe, Andrew12 (AUTHOR), Ravaud, Alain13 (AUTHOR), Maillet, Denis14 (AUTHOR), Mendez, Maria Jose15 (AUTHOR), Suarez, Cristina16 (AUTHOR), Linch, Mark17 (AUTHOR), Prendergast, Aaron1 (AUTHOR), Tyson, Charlotte1 (AUTHOR), Stanoeva, Diana3 (AUTHOR)
Zdroj:	European Urology. Aug2022, Vol. 82 Issue 2, p212-222. 11p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect